New Study Shows Increasing Value of Real-World Data (RWD) in Clinical Trials

Interviews conducted with biopharma executives in a Tufts CSDD study reveals growing RWD adoption and ROI across all phases of drug development San Francisco, CA, April 7, 2026 – New research by Tufts Center for the Study of Drug Development (CSDD) documents the growing importance of real-world data (RWD) and real-world evidence (RWE) in clinical… The post New Study Shows Increasing Value of Real-World Data (RWD) in Clinical Trials appeared first on veranahealth.com .